ChipCare picks up $2.8 mln of planned $18.8 mln Series B round
Toronto diagnostic startup ChipCare Corp has so far secured $2.8 million for its planned $18.8 million Series B financing. ChipCare said it retained San Francisco's Biotech Alliances International as the lead investment banker for the fundraising. Founded in 2009, ChipCare leverages technology developed at the University of Toronto to deliver point-of-care diagnostics for HIV and other diseases to hard-to-reach populations. The funds raised will be used to bring its products to market. Last year, ChipCare raised a $5 million Series A financing led by Puffin Partners.
17 November 2016•2 mins read
